Complementary effects of sirolimus-eluting stents and glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention in diabetic patients: one-year follow up of a single-centre registry
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.